Odyssey Therapeutics, Inc. ($ODTX)
Filing Information
| Accession Number | 0001999371-26-010652 |
|---|---|
| Form Type | 4 |
| Filing Date | May 13, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
22,390,748
Total Value
$25,042,320.00
P&L
-0.3% ($83,333.34)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Former 10% Owner | Common Stock | โ | May 11, 2026 | Other Acquisition or Disposition | 423,111 | โ | โ | 423,111 | Indirect | See Explanation of Responses | View Details | |
Former 10% Owner | Common Stock | โ | May 11, 2026 | Other Acquisition or Disposition | 2,351 | $18.00 | $42,318.00 | 420,760 | Indirect | See Explanation of Responses | View Details | |
Former 10% Owner | Common Stock | โ | May 11, 2026 | Conversion | 1,880,497 | โ | โ | 2,301,257 | Indirect | See Explanation of Responses | View Details | |
Former 10% Owner | Common Stock | โ | May 11, 2026 | Purchase | 1,388,889 | $18.00 | $25,000,002.00 | 3,690,146 | Indirect | See Explanation of Responses | View Details | |
Former 10% Owner | Warrants (right to buy) | Derivative | May 11, 2026 | Other Acquisition or Disposition | 423,111 | โ | โ | 0 | Indirect | See Explanation of Responses | View Details | |
Former 10% Owner | Series D Preferred Stock | Derivative | May 11, 2026 | Conversion | 18,272,789 | โ | โ | 0 | Indirect | See Explanation of Responses | View Details |